Contract 36C25726N0093
Optum Infusion Services 308, Llc · Department Of Veterans Affairs · October 27, 2025
Optum Infusion Services 308, Llc was awarded a federal contract by Department Of Veterans Affairs on October 27, 2025 for $225,000 of work in pharmaceutical preparation manufacturing. Performance is in Amarillo, TX. This is a task or delivery order issued under parent IDIQ 36C25726D0022. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 10, 2026.
Contract details
- PIID
- 36C25726N0093
- Parent IDIQ
- 36C25726D0022
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Competed Under Sap
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Pharmacy Services
- Place of performance
- Amarillo, TX
- First action
- October 27, 2025
- Latest action
- March 10, 2026
Description
ADMINISTRATIVE MODIFICATION TO CORRECT PERIOD OF PERFORMANCE ON THE TASK ORDER
Modification timeline
-
March 10, 2026Mod P00002$0
-
January 22, 2026Mod P00001AMARILLO VA PHARMACY COMPOUNDING FOR ONCOLOGY MEDICATIONS--INCREASE MODIFICATION FOR $125K$125.0K
-
October 27, 2025Base awardAMARILLO VA PHARMACY COMPOUNDING FOR ONCOLOGY MEDICATIONS$100.0K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36C25726N0093?
Contract 36C25726N0093 is a federal contract awarded to Optum Infusion Services 308, Llc by Department Of Veterans Affairs on October 27, 2025 for $225,000 of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 2 times since the base award.
Who won contract 36C25726N0093?
Optum Infusion Services 308, Llc won contract 36C25726N0093 from Department Of Veterans Affairs.
How much is contract 36C25726N0093 worth?
Contract 36C25726N0093 has obligated $225,000 to date.